Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II).

MLA

Hornig, Nadine C., et al. “Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II).” The Journal of Clinical Endocrinology and Metabolism, vol. 103, no. 12, Dec. 2018, pp. 4617–27. EBSCOhost, https://doi.org/10.1210/jc.2018-00052.

APA

Hornig, N. C., Rodens, P., Dörr, H., Hubner, N. C., Kulle, A. E., Schweikert, H.-U., Welzel, M., Bens, S., Hiort, O., Werner, R., Gonzalves, S., Eckstein, A. K., Cools, M., Verrijn-Stuart, A., Stunnenberg, H. G., Siebert, R., Ammerpohl, O., & Holterhus, P.-M. (2018). Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II). The Journal of Clinical Endocrinology and Metabolism, 103(12), 4617–4627. https://doi.org/10.1210/jc.2018-00052

Chicago

Hornig, Nadine C, Pascal Rodens, Helmuth Dörr, Nina C Hubner, Alexandra E Kulle, Hans-Udo Schweikert, Maik Welzel, et al. 2018. “Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II).” The Journal of Clinical Endocrinology and Metabolism 103 (12): 4617–27. doi:10.1210/jc.2018-00052.